193 related articles for article (PubMed ID: 24275372)
1. Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review.
Coelho L; Veloso VG; Grinsztejn B; Luz PM
Braz J Infect Dis; 2014; 18(2):196-210. PubMed ID: 24275372
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
4. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
[TBL] [Abstract][Full Text] [Related]
5. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
Dore GJ; Hoy JF; Mallal SA; Li Y; Mijch AM; French MA; Cooper DA; Kaldor JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Sep; 16(1):39-43. PubMed ID: 9377123
[TBL] [Abstract][Full Text] [Related]
7. Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil.
Coelho L; Cardoso SW; Amancio RT; Moreira RI; Campos DP; Veloso VG; Grinsztejn B; Luz PM
PLoS One; 2014; 9(6):e98666. PubMed ID: 24901419
[TBL] [Abstract][Full Text] [Related]
8. AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS).
Bellamy R; Sangeetha S; Paton NI
BMC Infect Dis; 2004 Nov; 4():47. PubMed ID: 15538953
[TBL] [Abstract][Full Text] [Related]
9. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
10. The changing spectrum of AIDS index diseases in Canada.
Montaner JS; Le T; Hogg R; Ricketts M; Sutherland D; Strathdee SA; O'Shaughnessy M; Schechter MT
AIDS; 1994 May; 8(5):693-6. PubMed ID: 8060550
[TBL] [Abstract][Full Text] [Related]
11. Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.
Michaels SH; Clark R; Kissinger P
Clin Infect Dis; 1999 Aug; 29(2):468-9. PubMed ID: 10476778
[No Abstract] [Full Text] [Related]
12. Pulmonary infections in children with HIV infection.
Pérez Mato S; Van Dyke RB
Semin Respir Infect; 2002 Mar; 17(1):33-46. PubMed ID: 11891517
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex. Multicenter AIDS Cohort Study.
Lyles RH; Chu C; Mellors JW; Margolick JB; Detels R; Giorgi JV; Al-Shboul Q; Phair JP
AIDS; 1999 Feb; 13(3):341-9. PubMed ID: 10199224
[TBL] [Abstract][Full Text] [Related]
14. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
15. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
Palella FJ; Delaney KM; Moorman AC; Loveless MO; Fuhrer J; Satten GA; Aschman DJ; Holmberg SD
N Engl J Med; 1998 Mar; 338(13):853-60. PubMed ID: 9516219
[TBL] [Abstract][Full Text] [Related]
16. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
[TBL] [Abstract][Full Text] [Related]
17. Opportunistic infections update.
Proj Inf Perspect; 1999 Apr; (27):19-20. PubMed ID: 11366735
[TBL] [Abstract][Full Text] [Related]
18. [Clinical impact of combination antiretroviral therapy].
Gatanaga H
Nihon Rinsho; 2002 Apr; 60(4):739-44. PubMed ID: 11968781
[TBL] [Abstract][Full Text] [Related]
19. Severe opportunistic infections in AIDS patients with late-stage disease.
Lifson AR; Olson R; Roberts SG; Poscher ME; Drew WL; Conant MA
J Am Board Fam Pract; 1994; 7(4):288-91. PubMed ID: 7942097
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of preventing AIDS-related opportunistic infections.
Freedberg KA; Scharfstein JA; Seage GR; Losina E; Weinstein MC; Craven DE; Paltiel AD
JAMA; 1998 Jan; 279(2):130-6. PubMed ID: 9440663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
